Entero Healthcare Solutions Limited’s Board of Directors met on February 12, 2026, approving the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. Key actions included approving the grant of 5,000 fresh Employee Stock Options (ESOPs) under the 2023 plan. Furthermore, the Board officially approved the cancellation of the proposed acquisition of Khera Medisolutions Private Limited and AV Medisolutions Private Limited citing commercial reasons.
Board Meeting Outcome: February 12, 2026
The Board of Directors of Entero Healthcare Solutions Limited convened on February 12, 2026, between 03:00 P.M. and 05:30 P.M. IST, concluding with the approval of several significant corporate actions.
Financial Results Disclosure
The Board ratified the Unaudited Financial Results (Standalone and Consolidated) for the period ending December 31, 2025. These results, along with the unmodified Limited Review Reports from the Statutory Auditors, have been submitted as required.
Standalone Financial Highlights (Nine Months Ended Dec 31, 2025)
- Total Income stood at Rs. 3,430.76 Million.
- Profit Before Tax reached Rs. 181.48 Million.
- Profit After Tax for the period was Rs. 134.59 Million.
- Basic Earnings Per Share (EPS) was Rs. 3.09.
Consolidated Financial Highlights (Nine Months Ended Dec 31, 2025)
- Total Income reached Rs. 46,965.14 Million.
- Profit Before Tax was Rs. 1,213.89 Million.
- Profit After Tax for the nine months was Rs. 1,007.12 Million.
- Basic Earnings Per Share (EPS) was Rs. 20.00.
Employee Stock Option Grant
Following the approval of the Nomination & Remuneration Committee, the Board approved the grant of 5,000 (Five Thousand only) fresh Employee Stock Options (ESOPs) under the existing “Entero Employee Stock Option Plan 2023”. These options are granted at an exercise price of INR 804 per option and are subject to a vesting period between one and four years from the grant date.
Cancellation of Proposed Acquisitions
The Board formally approved the cancellation of the proposed acquisition of two entities: Khera Medisolutions Private Limited and AV Medisolutions Private Limited. These acquisitions had been previously announced on May 27, 2025, and August 08, 2025, but are now being cancelled due to commercial reasons.
Auditor’s Review Confirmation
The Statutory Auditors, MSKA & Associates LLP, provided an Independent Auditor’s Review Report with an unmodified conclusion on the standalone results. Separately, the auditors noted reliance on management-certified information for 29 subsidiaries in the consolidated results, confirming that nothing came to their attention to suggest material misstatement.
Note: An additional submission was made on the same date informing exchanges that the UDIN generation for the Consolidated Financial Results was temporarily delayed due to scheduled maintenance on the auditor’s portal.
Source: BSE
